Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation

A. De Hoyos, D. Chamberlain, R. Schvartzman, J. Ramirez, S. Kesten, T. L. Winton, J. Maurer

Research output: Contribution to journalArticle

26 Citations (Scopus)

Abstract

Using the recent standardization of the pathologic definitions for acute lung rejection, we prospectively evaluated 66 consecutive bronchoalveolar lavages (BAL) and transbronchial biopsy (TBB) specimens in 32 patients after lung transplantation. Clinical indications for bronchoscopies were surveillance (n=44), rejection (n=18), and infection (n=4). Bronchoalveolar lavages were obtained from the right middle lobe or lingula in single lung transplant and from both sites in double lung transplant recipients. Cytosmears for differential cell counts were performed and 400 to 500 cells were counted. Five to eight TBB specimens were taken from two different lobes and stained with hematoxylin-eosin, elastic trichrome, and silver methenamine. Sixty-four of 66 sets of biopsy specimens were satisfactory, but 3 were eliminated because of presence of cytomegalovirus cytopathic changes. Of the remaining 61, rejection was present in 45 (74 percent): grade 1 in 23 (38 percent), grade 2 in 19 (31 percent), and grade 3 in 3 (5 percent). In 30 of 42 (71 percent) surveillance biopsy specimens, rejection was present, grade 1 in 18 (43 percent) and grade 2 or 3 in 12 (28 percent). In TBBs performed for clinical suspicion of rejection, 15 of 18 TBB specimens (83 percent) showed rejection, grade 1 in 5 (28 percent) and grade 2 or 3 in 10 (55 percent). Of four biopsies performed for suspicion of infection, one was normal and three showed rejection in addition to infection. These three were eliminated from further analysis due to the limitation of the Lung Rejection Study Group criteria in distinguishing rejection from infection. Of the 45 episodes of rejection, 24 (53 percent) occurred during the first 3 months posttransplantation, 8 (18 percent) between 3 and 6 months and 13 (29 percent) after 6 months. Percentage of BAL lymphocytosis was significantly elevated in grade 2 or 3 rejection (28±4) when compared with grade 1 (15±3) or grade 0 (10±3) (p<0.001). Bronchoalveolar lavage lymphocytosis also correlated with severity of rejection (r=0.6). We conclude that according to the standardized criteria of the Lung Rejection Study Group, acute lung rejection occurs more frequently than clinically suspected early and late after transplantation and that BAL lymphocytosis correlates with the presence and severity of histologically proven rejection.

Original languageEnglish (US)
Pages (from-to)1813-1818
Number of pages6
JournalChest
Volume103
Issue number6
DOIs
StatePublished - Jan 1 1993

Fingerprint

Lung Transplantation
Bronchoalveolar Lavage
Biopsy
Lymphocytosis
Lung
Infection
Methenamine
Bronchoscopy
Hematoxylin
Eosine Yellowish-(YS)
Cytomegalovirus
Cell Count
Transplantation
Transplants

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine
  • Critical Care and Intensive Care Medicine
  • Cardiology and Cardiovascular Medicine

Cite this

De Hoyos, A., Chamberlain, D., Schvartzman, R., Ramirez, J., Kesten, S., Winton, T. L., & Maurer, J. (1993). Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. Chest, 103(6), 1813-1818. https://doi.org/10.1378/chest.103.6.1813

Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. / De Hoyos, A.; Chamberlain, D.; Schvartzman, R.; Ramirez, J.; Kesten, S.; Winton, T. L.; Maurer, J.

In: Chest, Vol. 103, No. 6, 01.01.1993, p. 1813-1818.

Research output: Contribution to journalArticle

De Hoyos, A, Chamberlain, D, Schvartzman, R, Ramirez, J, Kesten, S, Winton, TL & Maurer, J 1993, 'Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation', Chest, vol. 103, no. 6, pp. 1813-1818. https://doi.org/10.1378/chest.103.6.1813
De Hoyos, A. ; Chamberlain, D. ; Schvartzman, R. ; Ramirez, J. ; Kesten, S. ; Winton, T. L. ; Maurer, J. / Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation. In: Chest. 1993 ; Vol. 103, No. 6. pp. 1813-1818.
@article{5d9dc6327f864053a97906df4262cdba,
title = "Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation",
abstract = "Using the recent standardization of the pathologic definitions for acute lung rejection, we prospectively evaluated 66 consecutive bronchoalveolar lavages (BAL) and transbronchial biopsy (TBB) specimens in 32 patients after lung transplantation. Clinical indications for bronchoscopies were surveillance (n=44), rejection (n=18), and infection (n=4). Bronchoalveolar lavages were obtained from the right middle lobe or lingula in single lung transplant and from both sites in double lung transplant recipients. Cytosmears for differential cell counts were performed and 400 to 500 cells were counted. Five to eight TBB specimens were taken from two different lobes and stained with hematoxylin-eosin, elastic trichrome, and silver methenamine. Sixty-four of 66 sets of biopsy specimens were satisfactory, but 3 were eliminated because of presence of cytomegalovirus cytopathic changes. Of the remaining 61, rejection was present in 45 (74 percent): grade 1 in 23 (38 percent), grade 2 in 19 (31 percent), and grade 3 in 3 (5 percent). In 30 of 42 (71 percent) surveillance biopsy specimens, rejection was present, grade 1 in 18 (43 percent) and grade 2 or 3 in 12 (28 percent). In TBBs performed for clinical suspicion of rejection, 15 of 18 TBB specimens (83 percent) showed rejection, grade 1 in 5 (28 percent) and grade 2 or 3 in 10 (55 percent). Of four biopsies performed for suspicion of infection, one was normal and three showed rejection in addition to infection. These three were eliminated from further analysis due to the limitation of the Lung Rejection Study Group criteria in distinguishing rejection from infection. Of the 45 episodes of rejection, 24 (53 percent) occurred during the first 3 months posttransplantation, 8 (18 percent) between 3 and 6 months and 13 (29 percent) after 6 months. Percentage of BAL lymphocytosis was significantly elevated in grade 2 or 3 rejection (28±4) when compared with grade 1 (15±3) or grade 0 (10±3) (p<0.001). Bronchoalveolar lavage lymphocytosis also correlated with severity of rejection (r=0.6). We conclude that according to the standardized criteria of the Lung Rejection Study Group, acute lung rejection occurs more frequently than clinically suspected early and late after transplantation and that BAL lymphocytosis correlates with the presence and severity of histologically proven rejection.",
author = "{De Hoyos}, A. and D. Chamberlain and R. Schvartzman and J. Ramirez and S. Kesten and Winton, {T. L.} and J. Maurer",
year = "1993",
month = "1",
day = "1",
doi = "10.1378/chest.103.6.1813",
language = "English (US)",
volume = "103",
pages = "1813--1818",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

TY - JOUR

T1 - Prospective assessment of a standardized pathologic grading system for acute rejection in lung transplantation

AU - De Hoyos, A.

AU - Chamberlain, D.

AU - Schvartzman, R.

AU - Ramirez, J.

AU - Kesten, S.

AU - Winton, T. L.

AU - Maurer, J.

PY - 1993/1/1

Y1 - 1993/1/1

N2 - Using the recent standardization of the pathologic definitions for acute lung rejection, we prospectively evaluated 66 consecutive bronchoalveolar lavages (BAL) and transbronchial biopsy (TBB) specimens in 32 patients after lung transplantation. Clinical indications for bronchoscopies were surveillance (n=44), rejection (n=18), and infection (n=4). Bronchoalveolar lavages were obtained from the right middle lobe or lingula in single lung transplant and from both sites in double lung transplant recipients. Cytosmears for differential cell counts were performed and 400 to 500 cells were counted. Five to eight TBB specimens were taken from two different lobes and stained with hematoxylin-eosin, elastic trichrome, and silver methenamine. Sixty-four of 66 sets of biopsy specimens were satisfactory, but 3 were eliminated because of presence of cytomegalovirus cytopathic changes. Of the remaining 61, rejection was present in 45 (74 percent): grade 1 in 23 (38 percent), grade 2 in 19 (31 percent), and grade 3 in 3 (5 percent). In 30 of 42 (71 percent) surveillance biopsy specimens, rejection was present, grade 1 in 18 (43 percent) and grade 2 or 3 in 12 (28 percent). In TBBs performed for clinical suspicion of rejection, 15 of 18 TBB specimens (83 percent) showed rejection, grade 1 in 5 (28 percent) and grade 2 or 3 in 10 (55 percent). Of four biopsies performed for suspicion of infection, one was normal and three showed rejection in addition to infection. These three were eliminated from further analysis due to the limitation of the Lung Rejection Study Group criteria in distinguishing rejection from infection. Of the 45 episodes of rejection, 24 (53 percent) occurred during the first 3 months posttransplantation, 8 (18 percent) between 3 and 6 months and 13 (29 percent) after 6 months. Percentage of BAL lymphocytosis was significantly elevated in grade 2 or 3 rejection (28±4) when compared with grade 1 (15±3) or grade 0 (10±3) (p<0.001). Bronchoalveolar lavage lymphocytosis also correlated with severity of rejection (r=0.6). We conclude that according to the standardized criteria of the Lung Rejection Study Group, acute lung rejection occurs more frequently than clinically suspected early and late after transplantation and that BAL lymphocytosis correlates with the presence and severity of histologically proven rejection.

AB - Using the recent standardization of the pathologic definitions for acute lung rejection, we prospectively evaluated 66 consecutive bronchoalveolar lavages (BAL) and transbronchial biopsy (TBB) specimens in 32 patients after lung transplantation. Clinical indications for bronchoscopies were surveillance (n=44), rejection (n=18), and infection (n=4). Bronchoalveolar lavages were obtained from the right middle lobe or lingula in single lung transplant and from both sites in double lung transplant recipients. Cytosmears for differential cell counts were performed and 400 to 500 cells were counted. Five to eight TBB specimens were taken from two different lobes and stained with hematoxylin-eosin, elastic trichrome, and silver methenamine. Sixty-four of 66 sets of biopsy specimens were satisfactory, but 3 were eliminated because of presence of cytomegalovirus cytopathic changes. Of the remaining 61, rejection was present in 45 (74 percent): grade 1 in 23 (38 percent), grade 2 in 19 (31 percent), and grade 3 in 3 (5 percent). In 30 of 42 (71 percent) surveillance biopsy specimens, rejection was present, grade 1 in 18 (43 percent) and grade 2 or 3 in 12 (28 percent). In TBBs performed for clinical suspicion of rejection, 15 of 18 TBB specimens (83 percent) showed rejection, grade 1 in 5 (28 percent) and grade 2 or 3 in 10 (55 percent). Of four biopsies performed for suspicion of infection, one was normal and three showed rejection in addition to infection. These three were eliminated from further analysis due to the limitation of the Lung Rejection Study Group criteria in distinguishing rejection from infection. Of the 45 episodes of rejection, 24 (53 percent) occurred during the first 3 months posttransplantation, 8 (18 percent) between 3 and 6 months and 13 (29 percent) after 6 months. Percentage of BAL lymphocytosis was significantly elevated in grade 2 or 3 rejection (28±4) when compared with grade 1 (15±3) or grade 0 (10±3) (p<0.001). Bronchoalveolar lavage lymphocytosis also correlated with severity of rejection (r=0.6). We conclude that according to the standardized criteria of the Lung Rejection Study Group, acute lung rejection occurs more frequently than clinically suspected early and late after transplantation and that BAL lymphocytosis correlates with the presence and severity of histologically proven rejection.

UR - http://www.scopus.com/inward/record.url?scp=0027312107&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0027312107&partnerID=8YFLogxK

U2 - 10.1378/chest.103.6.1813

DO - 10.1378/chest.103.6.1813

M3 - Article

C2 - 8404105

AN - SCOPUS:0027312107

VL - 103

SP - 1813

EP - 1818

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -